Security key
82835W108
ARS Pharmaceuticals, Inc. - Common Stock, par value $0.0001 per share (SPRY)
CUSIP: 82835W108
Q4 2022 13F Holders as of 31 Dec 2022
- Type / Class
- Equity / Common Stock, par value $0.0001 per share
- Shares outstanding
- 99,255,583
- Total 13F shares
- 50,164,476
- Share change
- +19,674,795
- Total reported value
- $427,856,540
- Put/Call ratio
- 0%
- Price per share
- $8.53
- Number of holders
- 72
- Value change
- +$173,112,031
- Number of buys
- 46
- Number of sells
- 24
Report period
Q4 2022
Institutions
72
Top holders
10
SPRY full security history
Newer quarter: Q1 2023
Previous quarter: Q3 2022
ARS Pharmaceuticals, Inc. SEC filings
ARS Pharmaceuticals, Inc. company facts
Broader feeds
Reporting periods
Holder history for CUSIP 82835W108
Recent filing periods:
Top shareholders of SPRY - ARS Pharmaceuticals, Inc. - Common Stock, par value $0.0001 per share (13F + 13D/G + 3/4/5)
Grouped by holder across the latest SEC ownership disclosures. Ownership % is shown only when it is directly reported or safely comparable across share classes.
Methodology: rows are grouped by holder and ranked by the holder's primary source value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.
| Holder | Source | Role / Reporting | Ownership % | Shares | Holdings Value | 12M Net Δ | As of | Details |
|---|---|---|---|---|---|---|---|---|
| ORBIMED ADVISORS LLC |
13F
|
Company |
8.8%
|
8,740,887
|
$46,152,000 | — | 30 Sep 2022 | |
| FMR LLC |
13F
|
Company |
4.8%
|
4,763,501
|
$25,152,000 | — | 30 Sep 2022 | |
| K2 PRINCIPAL FUND, L.P. |
13F
|
Company |
3.3%
|
3,247,533
|
$16,890,000 | — | 30 Sep 2022 | |
| Rubric Capital Management LP |
13F
|
Company |
2.7%
|
2,695,170
|
$14,230,000 | — | 30 Sep 2022 | |
| Nextech Invest Ltd. |
13F
|
Company |
1.9%
|
1,910,029
|
$10,085,000 | — | 30 Sep 2022 | |
| Nantahala Capital Management, LLC |
13F
|
Company |
1.3%
|
1,249,863
|
$6,599,000 | — | 30 Sep 2022 | |
| VANGUARD GROUP INC |
13F
|
Company |
1.1%
|
1,087,171
|
$5,740,000 | — | 30 Sep 2022 | |
| SECTORAL ASSET MANAGEMENT INC |
13F
|
Company |
1.1%
|
1,045,234
|
$5,519,000 | — | 30 Sep 2022 | |
| Woodline Partners LP |
13F
|
Company |
0.82%
|
812,899
|
$4,292,000 | — | 30 Sep 2022 | |
| BlackRock Finance, Inc. |
13F
|
Company |
0.73%
|
727,704
|
$3,842,000 | — | 30 Sep 2022 | |
| JACOBS LEVY EQUITY MANAGEMENT, INC |
13F
|
Company |
0.45%
|
450,834
|
$2,380,000 | — | 30 Sep 2022 | |
| TANG CAPITAL MANAGEMENT LLC |
13F
|
Company |
0.41%
|
409,463
|
$2,162,000 | — | 30 Sep 2022 | |
| MILLENNIUM MANAGEMENT LLC |
13F
|
Company |
0.35%
|
349,280
|
$1,844,000 | — | 30 Sep 2022 | |
| DIMENSIONAL FUND ADVISORS LP |
13F
|
Company |
0.33%
|
330,734
|
$1,747,000 | — | 30 Sep 2022 | |
| Oasis Management Co Ltd. |
13F
|
Company |
0.32%
|
317,662
|
$1,677,000 | — | 30 Sep 2022 | |
| RENAISSANCE TECHNOLOGIES LLC |
13F
|
Company |
0.32%
|
314,400
|
$1,660,000 | — | 30 Sep 2022 | |
| TWO SIGMA ADVISERS, LP |
13F
|
Company |
0.27%
|
269,800
|
$1,425,000 | — | 30 Sep 2022 | |
| GEODE CAPITAL MANAGEMENT, LLC |
13F
|
Company |
0.23%
|
224,384
|
$1,184,000 | — | 30 Sep 2022 | |
| Prosight Management, LP |
13F
|
Company |
0.2%
|
196,257
|
$1,036,000 | — | 30 Sep 2022 | |
| NEW YORK LIFE INVESTMENT MANAGEMENT LLC |
13F
|
Company |
0.15%
|
144,278
|
$762,000 | — | 30 Sep 2022 | |
| TWO SIGMA INVESTMENTS, LP |
13F
|
Company |
0.12%
|
116,800
|
$617,000 | — | 30 Sep 2022 | |
| GOLDMAN SACHS GROUP INC |
13F
|
Company |
0.1%
|
99,652
|
$526,000 | — | 30 Sep 2022 | |
| CITADEL ADVISORS LLC |
13F
|
Company |
0.1%
|
97,470
|
$515,000 | — | 30 Sep 2022 | |
| BRIDGEWAY CAPITAL MANAGEMENT, LLC |
13F
|
Company |
0.1%
|
96,144
|
$508,000 | — | 30 Sep 2022 | |
| Janney Montgomery Scott LLC |
13F
|
Company |
0.08%
|
82,033
|
$433,000 | — | 30 Sep 2022 | |
| Ergoteles LLC |
13F
|
Company |
0.08%
|
74,544
|
$394,000 | — | 30 Sep 2022 | |
| STATE STREET CORP |
13F
|
Company |
0.07%
|
67,591
|
$357,000 | — | 30 Sep 2022 | |
| MORGAN STANLEY |
13F
|
Company |
0.06%
|
56,065
|
$295,000 | — | 30 Sep 2022 | |
| Jonathan Piazza |
3/4/5
|
Chief Financial Officer |
—
mixed-class rows
|
156,608
mixed-class rows
|
$261,878 | — | 02 May 2022 | |
| PUBLIC EMPLOYEES RETIREMENT SYSTEM OF OHIO |
13F
|
Company |
0.05%
|
47,953
|
$253,000 | — | 30 Sep 2022 | |
| Valerie Odegard |
3/4/5
|
President and CSO |
—
mixed-class rows
|
152,106
mixed-class rows
|
$233,180 | — | 02 May 2022 | |
| NORTHERN TRUST CORP |
13F
|
Company |
0.04%
|
39,284
|
$207,000 | — | 30 Sep 2022 | |
| Naomi Hunder |
3/4/5
|
Chief Medical Officer |
—
mixed-class rows
|
140,782
mixed-class rows
|
$205,897 | — | 02 May 2022 | |
| Jeffrey C. Pepe |
3/4/5
|
Interim CEO and GC |
—
class O/S missing
|
52,323
|
$197,938 | — | 02 Sep 2022 | |
| AMERIPRISE FINANCIAL INC |
13F
|
Company |
0.04%
|
37,295
|
$197,000 | — | 30 Sep 2022 | |
| Avantax Planning Partners, Inc. |
13F
|
Company |
0.03%
|
32,174
|
$170,000 | — | 30 Sep 2022 | |
| D. E. Shaw & Co., Inc. |
13F
|
Company |
0.03%
|
29,289
|
$155,000 | — | 30 Sep 2022 | |
| Russ Hawkinson |
3/4/5
|
Sr. Vice President of Finance |
—
mixed-class rows
|
93,921
mixed-class rows
|
$140,921 | — | 02 May 2022 | |
| PRICE T ROWE ASSOCIATES INC /MD/ |
13F
|
Company |
0.03%
|
26,500
|
$140,000 | — | 30 Sep 2022 | |
| STATE OF WISCONSIN INVESTMENT BOARD |
13F
|
Company |
0.02%
|
24,200
|
$128,000 | — | 30 Sep 2022 | |
| BARCLAYS PLC |
13F
|
Company |
0.02%
|
19,985
|
$106,000 | — | 30 Sep 2022 | |
| ALGERT GLOBAL LLC |
13F
|
Company |
0.02%
|
19,920
|
$105,000 | — | 30 Sep 2022 | |
| PRELUDE CAPITAL MANAGEMENT, LLC |
13F
|
Company |
0.02%
|
19,694
|
$104,000 | — | 30 Sep 2022 | |
| Qube Research & Technologies Ltd |
13F
|
Company |
0.02%
|
16,425
|
$87,000 | — | 30 Sep 2022 | |
| OCCUDO QUANTITATIVE STRATEGIES LP |
13F
|
Company |
0.02%
|
15,057
|
$80,000 | — | 30 Sep 2022 | |
| JANE STREET GROUP, LLC |
13F
|
Company |
0.01%
|
14,183
|
$75,000 | — | 30 Sep 2022 | |
| APOGEM CAPITAL LLC |
13F
|
Company |
0.01%
|
13,793
|
$73,000 | — | 30 Sep 2022 | |
| QUATTRO FINANCIAL ADVISORS LLC |
13F
|
Company |
0.01%
|
12,869
|
$68,000 | — | 30 Sep 2022 | |
| TWO SIGMA SECURITIES, LLC |
13F
|
Company |
0.01%
|
12,740
|
$67,000 | — | 30 Sep 2022 | |
| Schonfeld Strategic Advisors LLC |
13F
|
Company |
0.01%
|
11,600
|
$62,000 | — | 30 Sep 2022 |
Institutional Holders of ARS Pharmaceuticals, Inc. - Common Stock, par value $0.0001 per share (SPRY) as of Q4 2022
As of 31 Dec 2022,
ARS Pharmaceuticals, Inc. - Common Stock, par value $0.0001 per share (SPRY) was held by
72 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
50,164,476 shares.
The largest 10 holders included
DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C), ORBIMED ADVISORS LLC, FMR LLC, RA CAPITAL MANAGEMENT, L.P., SR ONE CAPITAL MANAGEMENT, LP, Rubric Capital Management LP, K2 PRINCIPAL FUND, L.P., BAKER BROS. ADVISORS LP, Nextech Invest Ltd., and VANGUARD GROUP INC.
This page lists
72
institutional shareholders reporting positions in this security
for the Q4 2022 filing period.
| Investor | Option | Weight % | Change % | Value $ | * Price | Shares | Share Change | Activity | Report Period |
|---|
Compare Q4 2022 vs Q3 2022 Across Filers
Q3 2022 holders
58
Q4 2022 holders
72
Holder diff
14
| Investor | Q3 2022 Shares | Q4 2022 Shares | Share Diff | Share Chg % | Q3 2022 Value $ | Q4 2022 Value $ | Value Diff $ | Value Chg % |
|---|
Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).
Quarterly Holders Trend
Quarterly Value Trend
Quarterly Shares Trend
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.
An asterisk sign (*) next to the price indicates that the price is likely invalid.